Amgen Inc.: PharmaVitae Profile

Introduction

This analysis examines the historical and forecast performance for Amgen in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase

*Benchmark Amgen's performance against key rivals in the prescription pharmaceutical sector

*Assess how Amgen's commercial performance out to 2015 will be impacted by the safety concerns relating to the ESA product class

*Analyze Amgen's diversification strategy which will be heavily reliant on the launch of the cross-therapy area monoclonal antibody Prolia


Report Highlights

[Cerrar las informaciones del articulo de mercado]